| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/10/2005 | US20050053996 Detecting trace quantities of a molecular target by exploiting a specific interaction between the target and two molecular probes; identifying restriction fragment length polymorphisms; gene expression analysis |
| 03/10/2005 | US20050053995 Staphylococcus aureus genes and polypeptides |
| 03/10/2005 | US20050053992 Methods for screening cellular proliferation using isotope labels |
| 03/10/2005 | US20050053990 Identifying RNA viral sequences using restriction enzymes specific for RNA/DNA duplexes; primer biosynthesis; pathogen detection |
| 03/10/2005 | US20050053989 Libraries of recombinant chimeric proteins |
| 03/10/2005 | US20050053986 Compositions and methods for analysis of nucleic acids |
| 03/10/2005 | US20050053985 Multimeric protein comprising cleavage-polyadenylation specificity factor for use in identifying modulator for treatment and prevention of cell proliferative disorders |
| 03/10/2005 | US20050053984 Isoaspartyl repair |
| 03/10/2005 | US20050053980 used to genotype individuals on a genome-wide scale; simultaneously detecting large numbers of typable loci for an amplified representative population of genome fragments using genetic probes having sequences corresponding to the typable loci |
| 03/10/2005 | US20050053979 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same |
| 03/10/2005 | US20050053978 Pharmacophore model generation and use |
| 03/10/2005 | US20050053977 Methods for treating lentivirus infections |
| 03/10/2005 | US20050053976 Chimeric oligomeric compounds and their use in gene modulation |
| 03/10/2005 | US20050053975 Using restriction fragment primers as tool in detecting polymorphisms in plant genomes |
| 03/10/2005 | US20050053974 Apparatus and methods for surface plasmon-coupled directional emission |
| 03/10/2005 | US20050053973 Generating multimers from two or more discrete monomer domains for use in identifying immuno-domains and ligands; recombinant mosaic proteins and drug screening |
| 03/10/2005 | US20050053972 Method for identifying polymorphisms |
| 03/10/2005 | US20050053971 Methods and constructs for developing cell lines for biological assays |
| 03/10/2005 | US20050053970 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype |
| 03/10/2005 | US20050053967 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| 03/10/2005 | US20050053966 Apparatus and method for the analysis of nucleic acids hydbridization on high density NA chips |
| 03/10/2005 | US20050053965 Double stranded RNA compound for use the prevention and treatment of inflammatory and autoimmune disorders |
| 03/10/2005 | US20050053964 Oligonucleotide identifiers |
| 03/10/2005 | US20050053963 Reducing background in hybridization reactions |
| 03/10/2005 | US20050053962 Amplification of nucleic acids with electronic detection |
| 03/10/2005 | US20050053961 Analysis system comprising structure of an ion-permeable passage connecting first AND second pools; molecular motor of processive nucleic acid translocation is not bacteriophage receptor; differentiation between hybridized nucleotide monomers before entering channel |
| 03/10/2005 | US20050053960 Reagents and methods useful for detecting diseases of the breast |
| 03/10/2005 | US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders |
| 03/10/2005 | US20050053957 Polynucleotide sequence detection assays |
| 03/10/2005 | US20050053956 Using klotho gene expression as diagnostic indicator of cardiovascular disorders; high throughput assay |
| 03/10/2005 | US20050053955 Nucleic acid-based assay and kit for the detection of methanogens in biological samples |
| 03/10/2005 | US20050053954 Multicomponent protein microarrays |
| 03/10/2005 | US20050053952 Microfluidic nucleic acid analysis |
| 03/10/2005 | US20050053950 Protocol and software for multiplex real-time PCR quantification based on the different melting temperatures of amplicons |
| 03/10/2005 | US20050053949 Biochip for proteomics applications |
| 03/10/2005 | US20050053948 Preparing a reaction mixture, dissociating the sample DNA to create single stranded templates, annealing primers to primer sites, extending the annealed primers to generate a series of fluorescently-labeled dideoxynucleic acid fragments, heating, repeating, determining nucleotide sequence of sample DNA |
| 03/10/2005 | US20050053946 Method for analyzing activation pathways controlled by neurotransmitters |
| 03/10/2005 | US20050053945 Nucleosides; bioconjugation; solid phase synthesis |
| 03/10/2005 | US20050053944 Using microarray comprised of immobilized peptide nucleic acids as probes for detection of preferential DNA or RNA target sequences |
| 03/10/2005 | US20050053942 Using locked nucleic acids as tools in detection of homopolymeric sequences; genomic analysis; detecting viral nucleotide sequences |
| 03/10/2005 | US20050053941 Extraction of nucleic acid |
| 03/10/2005 | US20050053937 Using DNA methylation patterns as diagnostic and prognostic indicator of cell proliferative, psychological, connective tissue nervous system and cardiovascular disorders |
| 03/10/2005 | US20050053936 High-throughput transcriptome and functional validation analysis |
| 03/10/2005 | US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 03/10/2005 | US20050053934 Method of selecting barley variety, barley beta-amylase gene and process for producing malt alcoholic drink |
| 03/10/2005 | US20050053933 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof |
| 03/10/2005 | US20050053930 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/10/2005 | US20050053929 Using transposase transgenesis as tool in correlating phenotype and genic action |
| 03/10/2005 | US20050053928 Arrays for detecting nucleic acids |
| 03/10/2005 | US20050053927 Rifamycin biosynthesis gene cluster |
| 03/10/2005 | US20050053926 Nucleic Acid displacer compositions and cells comprising same |
| 03/10/2005 | US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference |
| 03/10/2005 | US20050053920 Retrovirus from the HIV group and its use |
| 03/10/2005 | US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection |
| 03/10/2005 | US20050053916 Using sequence analysis to identify mutational variation in hepatitis b virus; prognosing response to viral infection; monitoring effectiveness of lamivudine carrier in treatment and prevention of viral infection |
| 03/10/2005 | US20050053915 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products |
| 03/10/2005 | US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases |
| 03/10/2005 | US20050053913 Reverse two-hybrid systems |
| 03/10/2005 | US20050053626 Using the small pox vaccine to treat genital herpes |
| 03/10/2005 | US20050053617 Peptides or polypeptides of HCV NS3 protein used to determine antibodies and fusion proteins |
| 03/10/2005 | US20050053607 Proteins for treatment of cancer by administering antinucleolin |
| 03/10/2005 | US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/10/2005 | US20050053594 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
| 03/10/2005 | US20050051744 Fluorescence detecting device |
| 03/10/2005 | US20050051723 Examination systems for biological samples |
| 03/10/2005 | US20050051706 Uncaging device |
| 03/10/2005 | US20050051440 Electrochemical sensors including electrode systems with increased oxygen generation |
| 03/10/2005 | CA2564426A1 A device for the detection of microorganisms using signal amplification |
| 03/10/2005 | CA2543078A1 Diagnosis and treatment of micobacterial infections |
| 03/10/2005 | CA2539953A1 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 03/10/2005 | CA2538513A1 Soluble analyte detection and amplification |
| 03/10/2005 | CA2537529A1 Signal amplification using a synthetic zymogen |
| 03/10/2005 | CA2537403A1 In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders |
| 03/10/2005 | CA2537256A1 Method for density measurement of mycelium and uses thereof |
| 03/10/2005 | CA2537249A1 Methods for detecting and quantifying specific microorganisms |
| 03/10/2005 | CA2537183A1 Improved bisulfite method employing size exclusion step |
| 03/10/2005 | CA2537151A1 Novel vector and utilization of the same |
| 03/10/2005 | CA2537140A1 Gastric and prostate cancer associated antigens |
| 03/10/2005 | CA2537134A1 Ola-based methods for the detection of target nucleic acid sequences |
| 03/10/2005 | CA2537115A1 Methods for the early diagnosis of ovarian cancer |
| 03/10/2005 | CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription |
| 03/10/2005 | CA2537034A1 Mass spectrometry methods for simultaneous detection of metabolic enzyme activity and metabolite levels |
| 03/10/2005 | CA2537031A1 Pathogenic gene for coronary artery disease |
| 03/10/2005 | CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 03/10/2005 | CA2536621A1 Method for identifying selective growth inhibitors |
| 03/10/2005 | CA2536335A1 Multi-allelic molecular detection of sars-associated coronavirus |
| 03/10/2005 | CA2536324A1 Hepatocellular cancer-associated gene |
| 03/10/2005 | CA2536205A1 Human obesity susceptibility gene and uses thereof |
| 03/10/2005 | CA2536191A1 Nanoparticles for delivery of nucleic acids and stable double-stranded rna |
| 03/10/2005 | CA2535902A1 Uses of spatial configuration to modulate protein function |
| 03/10/2005 | CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them |
| 03/10/2005 | CA2533659A1 Liquid crystal based analyte detection |
| 03/10/2005 | CA2533572A1 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching |
| 03/10/2005 | CA2531768A1 Chrna2 genetic markers associated with galantamine response |
| 03/10/2005 | CA2530350A1 Digital cell |
| 03/10/2005 | CA2530221A1 Modified molecular beacons |
| 03/10/2005 | CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 03/10/2005 | CA2529027A1 D-amino acid peptides |
| 03/10/2005 | CA2526128A1 Severe acute respiratory syndrome dna vaccine compositions and methods of use |
| 03/10/2005 | CA2516326A1 Compositions and methods for screening using populations of surrogate antibodies which comprise aptamers |